Vectus Biosystems (ASX:VBS) Short Percentage of Float


ASX:VBS Vectus Biosystems Ltd ASX:VBS
18 GF Score
Price A$0.13
! 2 Warning Signs
View Full Analysis

What is Vectus Biosystems Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:VBS vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Vectus Biosystems's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Short Percentage of Float falls into.


ASX:VBS
18GF Score
Vectus Biosystems Ltd ASX:VBS
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vectus Biosystems Business Description

Address 26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.
18GF Score

Get the complete analysis for ASX:VBS

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.13
Price